KK
ANIP icon

KLP Kapitalforvaltning’s ANI Pharmaceuticals ANIP Stock Holding History

KLP Kapitalforvaltning’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
15,300
+3,500
+30% +$281K ﹤0.01% 1002
2026
Q1 		$907K Hold
11,800
– – ﹤0.01% 1082
2025
Q4 		$931K Buy
11,800
+8,100
+219% +$701K ﹤0.01% 1067
2025
Q3 		$339K Hold
3,700
– – ﹤0.01% 1600
2025
Q2 		$241K Buy
3,700
+700
+23% +$45.6K ﹤0.01% 1703
2025
Q1 		$201K Hold
3,000
– – ﹤0.01% 1741
2024
Q4 		$166K Buy
+3,000
New +$172K ﹤0.01% 1904

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's ANIP Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its ANI Pharmaceuticals (ANIP) stake by 30% in Q2 2026, buying an estimated $281K and bringing the position to 15,300 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

KLP Kapitalforvaltning first reported a position in ANIP in Q4 2024 and has held it in 7 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • KLP Kapitalforvaltning held 15,300 shares of ANI Pharmaceuticals worth $1.27M as of Q2 2026.
  • KLP Kapitalforvaltning bought 3,500 ANI Pharmaceuticals shares in Q2 2026, an estimated $281K.
  • ANI Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1002 holding.
  • KLP Kapitalforvaltning first reported a position in ANI Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.